ArticleBone marrow transplantation2026
Second alternative-donor haploidentical stem cell transplantation enhances survival in patients with myeloid malignancies complicated by posttransplant human leukocyte antigen loss relapse.
Xiao-Tong Chen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.